Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital

Clicks: 424
ID: 112609
2004
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #2 of 38 articles by views in current medical research and opinion

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The University of Kentucky Hospital investigated the feasibility of choosing a sole fluoroquinolone for its formulary in an effort to reduce costs without affecting clinical outcomes. A three-step process was used to plan, implement, and monitor the selection program. Based on the range of clinical …
Reference Key
rp2004currentdrug Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rapp RP;Evans ME;Martin C;Ofotokum I;Empey KL;Armitstead JA;;
Journal current medical research and opinion
Year 2004
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/15119984
Keywords
University National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine anti-bacterial agents / therapeutic use bacteria / drug effects anti-bacterial agents / adverse effects fluoroquinolones / therapeutic use microbial sensitivity tests ciprofloxacin / therapeutic use hospitals levofloxacin* drug costs ciprofloxacin / pharmacokinetics ofloxacin / pharmacokinetics pmid:15119984 doi:10.1185/030079904125003223 robert p rapp martin e evans john a armitstead anti-bacterial agents / economics* anti-bacterial agents / pharmacokinetics ciprofloxacin / adverse effects ciprofloxacin / economics cost savings fluoroquinolones / adverse effects fluoroquinolones / economics* fluoroquinolones / pharmacokinetics formularies hospital as topic* hospital costs ofloxacin / adverse effects ofloxacin / economics* ofloxacin / therapeutic use organizational policy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.